Preclinical Bioavailability, Tissue Distribution, and Protein Binding Studies of Erinacine A, a Bioactive Compound from <i>Hericium erinaceus</i> Mycelia Using Validated LC-MS/MS Method

Erinacine A, derived from the mycelia of <i>Hericium erinaceus</i>, has attracted much attention due to its neuroprotective properties. However, very few studies have been conducted on the bioavailability, tissue distribution, and protein binding of erinacine A. This study aimed to investigate the b...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Pei-Ching Tsai, Yi-Kai Wu, Jun-Hao Hu, I-Chen Li, Ting-Wei Lin, Chin-Chu Chen, Chia-Feng Kuo
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2021-07-01
Rangatū:	Molecules
Ngā marau:	<i>Hericium erinaceus</i> mycelia erinacine A bioavailability tissue distribution excretion
Urunga tuihono:	https://www.mdpi.com/1420-3049/26/15/4510
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!